RHJA
BVS icon

Rice Hall James & Associates’s Bioventus BVS Stock Holding History

Rice Hall James & Associates’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-533,322
Closed -$3.73M – 263
2022
Q3 		$3.73M Sell
533,322
-1,774
-0.3% -$13.9K 0.22% 109
2022
Q2 		$3.65M Sell
535,096
-1,754
-0.3% -$17.9K 0.18% 112
2022
Q1 		$7.57M Buy
536,850
+752
+0.1% +$10.1K 0.3% 77
2021
Q4 		$7.77M Buy
536,098
+165,269
+45% +$2.35M 0.28% 76
2021
Q3 		$5.25M Buy
+370,829
New +$5.71M 0.19% 94

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Rice Hall James & Associates's BVS Position: Q4 2022 in Review

Rice Hall James & Associates sold out of Bioventus (BVS) in Q4 2022, closing a stake of 533,322 shares — an estimated $3.73M sold.

Rice Hall James & Associates first reported a position in BVS in Q3 2021 and held it in 5 quarters. The position peaked at $7.77M in Q4 2021. 85 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Rice Hall James & Associates reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 533,322 Bioventus shares in Q4 2022, an estimated $3.73M.
  • Rice Hall James & Associates first reported a position in Bioventus in Q3 2021 and held it in 5 quarters.
  • Rice Hall James & Associates's Bioventus position peaked at $7.77M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.